http://www.aasraw.com/products/rimonabant-powder/ - Rimonabant is an anorectic anti-obesity drug and Rimonabant powder is the raw material for many weight loss supplement, such as Rimonabant are Zimulti, Acomplia, Monaslim, Bethin, Riobant, Remonabent, Rimoslim and Riomont in the market.Rimonabant powder can help you to loss weight effectively.
Email: email@example.com Whatsapp:+8618928439036 with a BMI greater than 30 or people whose BMI was greater than 27 but who had other risk factors like dyslipidemia and type 2-diabetes. In June 2006, European Commission approved its sale and it was submitted to FDA for US approval. However, FDA’s EMDAC voted against the drug, concluding that Sanofi-Aventis, the manufacturers of Rimonabant, had not demonstrated its safety effectively. In 2009, EMEA withdrew Acomplia, after suspending it in 2008, because of severe psychological side effects of the drug, such as suicidal tendencies. FDA never approved Rimonabant and therefore, it has never been marketed in the US. 2. Rimonabant Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression. 2
Email: firstname.lastname@example.org Whatsapp:+8618928439036 3. Brand Name of Rimonabant Variations Other names for Rimonabant are Zimulti, Acomplia, Monaslim, Bethin, Riobant, Remonabent, Rimoslim and Riomont. 4. Rimonabant powder Product Name Rimonabant powder CAS 168273-06-1 Molecular Formula C22H21Cl3N4O Molecular Weight 463.79 Melt Point 230-240ºC Storage Temp Refrigerator Color White or off white Crystalline powder 5. Mechanism of action-- Rimonabant powder Rimonabant is a specific CB1 cannabinoid receptor antagonist. There is considerable evidence that the endocannabinoid (endogenous cannabinoid) system plays a significant role in appetitive drive and associated behaviours. It is therefore reasonable to hypothesize that the attenuation of the activity of this system would have therapeutic benefit in treating disorders that might have a component of excess appetitive drive or over-activity of the endocannabinoid system, such as obesity, ethanol and other drug abuse, and a variety of central nervous system and other disorders. 6. How does Rimonabant powder work? • Rimonabant powder acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) 3